SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-19-235386
Filing Date
2019-08-30
Accepted
2019-08-30 17:16:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10868
2 GRAPHIC g788934gra2.jpg GRAPHIC 8456
  Complete submission text file 0001193125-19-235386.txt   23568
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances